Differential, dominant activation and inhibition of notch signalling and APP cleavage by truncations of PSEN1 in human disease deficits
Authors/Creators
Morgan Newman
Lachlan Wilson
Guiseppe Verdile, Edith Cowan UniversityFollow
Anne Lim
Imran Khan, Edith Cowan UniversityFollow
Seyyed Hani Moussavi Nik
Sharon Pursglove
Gavin Chapman
Ralph N. Martins, Edith Cowan UniversityFollow
Michael Lardelli
Abstract
PRESENILIN1 (PSEN1) is the major locus for mutations causing familial Alzheimer's disease (FAD) and is alsomutated in Pick disease of brain, familial acne inversa and dilated cardiomyopathy. It is a critical facilitator of Notch signalling and many other signalling pathways and protein cleavage events including production of theAmyloidb (Aβ) peptide from the AMYLOID BETA A4 PRECURSOR PROTEIN (APP). We previously reported that interference with splicing of transcripts of the zebrafish orthologue of PSEN1 creates dominant negative effects on Notch signalling. Here,we extend this work to show that various truncations of human PSEN1 (or zebrafish Psen1) protein have starkly differential effects on Notch signalling and cleavage of zebrafish Appa (a paralogue of human APP). Different truncations can suppress or stimulate Notch signalling but not Appa cleavage and vice versa. The G183V mutation possibly causing Pick disease causes production of aberrant transcripts truncating the open reading frameafter exon 5 sequence. We show that the truncated protein potentially translated from these transcripts avidly incorporates into very stable Psen1-dependent higher molecular weight complexes and suppresses cleavage of Appa but not Notch signalling. In contrast, the truncated protein potentially produced by the P242LfsX11 acne inversa mutation has no effect on Appac leavage but,unexpectedly, enhances Notch signalling. Our results suggest novel hypotheses for the pathological mechanisms underlying these diseases and illustrate the importance of investigating the function of dominant mutations at physiologically relevant expression levels and in the normally heterozygous state in which they cause human disease rather than in isolation from healthy alleles.
Keywords
amyloid precursor protein, neurogenin 1, Notch receptor, presenilin 1, animal cell, animal experiment, article, embryo, exon, gene expression, gene mutation, gene sequence, genetic transcription, nonhuman, open reading frame, Pick presenile dementia, priority journal, protein cleavage, protein function, signal transduction, zebra fish, Amino Acid Sequence, Amyloid beta-Protein Precursor, Amyloidogenic Proteins, Animals, Base Sequence, Basic Helix-Loop-Helix Transcription Factors, Embryo, Nonmammalian, Exons, HEK293 Cells, Hidradenitis Suppurativa, Humans, Intracellular Membranes, Mice, Molecular Sequence Data, Molecular Weight, Mutation, Nerve Tissue Proteins, Pick Disease of the Brain, Presenilin-1, Presenilin-2, Receptors, Notch, Signal Transduction, Zebrafish, Zebrafish Proteins
Document Type
Journal Article
Date of Publication
1-1-2014
Faculty
Faculty of Health, Engineering and Science
Publisher
Oxford University Press
School
School of Medical Sciences
RAS ID
18790
Copyright
free_to_read
Comments
Newman M., Wilson L., Verdile G., Lim A., Khan I., Moussavi Nik S.H., Pursglove S., Chapman G., Martins R.N., & Lardelli M. (2014). Differential, dominant activation and inhibition of notch signalling and APP cleavage by truncations of PSEN1 in human disease deficits. Human Molecular Genetics, 23(3), 602-617. Available here